HEALTH Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada Saturday, May 16, 2026 Advertisement Read Original Article → Related Dispatches [US] · Jun 30 Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‐Vec in Ovarian Cancer [US] · Jun 30 Uncertainty Over Qatar Diplomacy Clouds Prospects for US-Iran Deal [EU] · Jun 30 Exclusive-US House Committee Opens Investigation Into Merck, AbbVie China Drug Trials